Evidence map›Paper›PMID 40391155›Full record

ArticleFrontiers in oncology2025

Interpretable multiparametric MRI radiomics-based machine learning model for preoperative differentiation between benign and malignant prostate masses: a diagnostic, multicenter study.

Wenjun Zhou, Zhangcheng Liu, Jindong Zhang, Shuai Su, Yu Luo, Lincen Jiang, Kun Han, Guohua Huang, Jue Wang, Jianhua Lan and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenjun Zhou *Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhangcheng Liu *Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jindong ZhangDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Shuai SuDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yu LuoDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lincen JiangDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Kun HanDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Guohua HuangDepartment of Urology, Guang'an People's Hospital, Guang'an, Sichuan, China.
Jue WangDepartment of Urology, Panzhihua Central Hospital, Panzhihua, Sichuan, China.
Jianhua LanDepartment of Urology, Guang'an People's Hospital, Guang'an, Sichuan, China.
Delin WangDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The study aimed to develop and externally validate multiparametric MRI (mpMRI) radiomics-based interpretable machine learning (ML) model for preoperative differentiating between benign and malignant prostate masses. Methods: Patients who underwent mpMRI with suspected malignant prostate masses were retrospectively recruited from two independent hospitals between May 2016 and May 2023. The prostate mass regions in T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) MRI images were segmented by ITK-SNAP. PyRadiomics was utilized to extract radiomic features. Inter- and intraobserver correlation analysis, t-test, Spearman correlation analysis, and the least absolute shrinkage and selection operator (LASSO) algorithm with a five-fold cross-validation were applied for feature selection. Five ML learning models were built using the chosen features. Model performance was evaluated with internal and external validation, using area under the curve (AUC), calibration curves, and decision curve analysis to select the optimal model. The interpretability of the most robust model was conducted via SHapley Additive exPlanation (SHAP). Results: A total of 567 patients were enrolled, consisting of the training (n = 352), internal test (n = 152), and external test (n = 63) sets. In total, 2,632 radiomic features were extracted from regions of interest (ROIs) of T2WI and DWI images, which were reduced to 18 via LASSO. Five ML models were established, among which the random forest (RF) model presented the best predictive ability, with AUCs of 0.929 (95% confidential interval [CI]: 0.885-0.963) and 0.852 (95% CI: 0.758-0.934) in the internal and external test sets, respectively. The calibration and decision curve analyses confirmed the excellent clinical usefulness of the RF model. Besides, the contributing relations of the radiomic features were uncovered using SHAP. Conclusions: Radiomic features from mpMRI combined with machine learning facilitate accurate preoperative evaluation of the malignancy in prostate masses. SHAP can disclose the underlying prediction process of the ML model, which may promote its clinical applications.

Indexed as

interpretationmachine learningmalignant prostate massmultiparametric magnetic resonance imagingradiomics

Identifiers

PMID40391155
PMCPMC12086068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.